 | • レポートコード：QYR9NV18306 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、心的外傷後ストレス障害治療法の世界市場について調査・分析し、心的外傷後ストレス障害治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の心的外傷後ストレス障害治療法市場動向 ・主要企業別マーケットシェア ・心的外傷後ストレス障害治療法の種類別市場規模2014-2019 （抗うつ薬、抗不安薬、その他） ・心的外傷後ストレス障害治療法の用途別市場規模2014-2019 （病院、診療所、その他） ・心的外傷後ストレス障害治療法の北米市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法の中国市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法の日本国内市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法のインド市場：主要企業・種類別/用途別市場規模 ・心的外傷後ストレス障害治療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer, Inc.、GlaxoSmithKline plc、Otsuka Pharmaceutical Co., Ltd、Novartis AG、AstraZeneca Plc、Azevan Pharmaceuticals, Inc.、Bionomics Ltd.、Tonix Pharmaceuticals Holding Corp.、Apotex, Inc.） ・心的外傷後ストレス障害治療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Post-Traumatic Stress Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post-Traumatic Stress Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.
Market segment by Type, the product can be split into
Antidepressants
Anti-Anxiety Drugs
Others
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Post-Traumatic Stress Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Post-Traumatic Stress Disorder Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Post-Traumatic Stress Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antidepressants
1.4.3 Anti-Anxiety Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Post-Traumatic Stress Disorder Therapeutics Market Size
2.2 Post-Traumatic Stress Disorder Therapeutics Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (2019-2025)
2.2.2 Post-Traumatic Stress Disorder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Post-Traumatic Stress Disorder Therapeutics Market Size by by Players
3.1.1 Global Post-Traumatic Stress Disorder Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Area Served
3.3 Key Players Post-Traumatic Stress Disorder Therapeutics Product/Solution/Service
3.4 Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2014-2019)
4.2 Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2014-2019)
5 North America
5.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
5.2 Post-Traumatic Stress Disorder Therapeutics Key Players in North America
5.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
5.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
6 Europe
6.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
6.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Europe
6.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type
6.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application
7 China
7.1 China Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
7.2 Post-Traumatic Stress Disorder Therapeutics Key Players in China
7.3 China Post-Traumatic Stress Disorder Therapeutics Market Size by Type
7.4 China Post-Traumatic Stress Disorder Therapeutics Market Size by Application
8 Japan
8.1 Japan Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
8.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Japan
8.3 Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Type
8.4 Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
9.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type
9.4 Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application
10 India
10.1 India Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
10.2 Post-Traumatic Stress Disorder Therapeutics Key Players in India
10.3 India Post-Traumatic Stress Disorder Therapeutics Market Size by Type
10.4 India Post-Traumatic Stress Disorder Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size (2014-2019)
11.2 Post-Traumatic Stress Disorder Therapeutics Key Players in Central & South America
11.3 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
11.4 Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer, Inc.
12.1.1 Pfizer, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019))
12.1.5 Pfizer, Inc. Recent Development
12.2 GlaxoSmithKline plc
12.2.1 GlaxoSmithKline plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline plc Recent Development
12.3 Otsuka Pharmaceutical Co., Ltd
12.3.1 Otsuka Pharmaceutical Co., Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 AstraZeneca Plc
12.5.1 AstraZeneca Plc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Plc Recent Development
12.6 Azevan Pharmaceuticals, Inc.
12.6.1 Azevan Pharmaceuticals, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.6.5 Azevan Pharmaceuticals, Inc. Recent Development
12.7 Bionomics Ltd.
12.7.1 Bionomics Ltd. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.7.5 Bionomics Ltd. Recent Development
12.8 Tonix Pharmaceuticals Holding Corp.
12.8.1 Tonix Pharmaceuticals Holding Corp. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
12.9 Apotex, Inc.
12.9.1 Apotex, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Post-Traumatic Stress Disorder Therapeutics Introduction
12.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
12.9.5 Apotex, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Post-Traumatic Stress Disorder Therapeutics Key Market Segments
Table Key Players Post-Traumatic Stress Disorder Therapeutics Covered
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antidepressants Figures
Table Key Players of Antidepressants
Figuer Anti-Anxiety Drugs Figures
Table Key Players of Anti-Anxiety Drugs
Figuer Others Figures
Table Key Players of Others
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Post-Traumatic Stress Disorder Therapeutics Report Years Considered
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions 2014-2019
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Post-Traumatic Stress Disorder Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Share by by Players (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Share by by Players in 2018
Table Global Post-Traumatic Stress Disorder Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Post-Traumatic Stress Disorder Therapeutics Product/Solution/Service
Table Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Type (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Application (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Application in 2018
Figure North America Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Europe Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure China Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table China Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table China Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Japan Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure India Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table India Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table India Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Figure Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Post-Traumatic Stress Disorder Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Post-Traumatic Stress Disorder Therapeutics Market Share (2018-2019)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Share by Type 2014-2019
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Post-Traumatic Stress Disorder Therapeutics Market Share by Application 2014-2019
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Otsuka Pharmaceutical Co., Ltd Company Details
Table Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Otsuka Pharmaceutical Co., Ltd Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table AstraZeneca Plc Company Details
Table AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table AstraZeneca Plc Recent Development
Table Azevan Pharmaceuticals, Inc. Company Details
Table Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Azevan Pharmaceuticals, Inc. Recent Development
Table Bionomics Ltd. Company Details
Table Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Bionomics Ltd. Recent Development
Table Tonix Pharmaceuticals Holding Corp. Company Details
Table Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Tonix Pharmaceuticals Holding Corp. Recent Development
Table Apotex, Inc. Company Details
Table Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business 2014-2019 (Million US$)
Figure Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2014-2019)
Table Apotex, Inc. Recent Development
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size Share by Regions in 2025
Figure North America Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Post-Traumatic Stress Disorder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Product in 2025
Table Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2019-2025)
Figure Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
心的外傷後ストレス障害治療法のグローバル市場：規模・現状・予測2019-2025 The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …- 心的外傷後ストレス障害（PTSD）治療学の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. Scope of the Report: This report focuses on the Post-Traumatic Stress Disorder (PTSD) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle Ea…
- 世界及び中国の不安障害治療薬市場2018 The 'Global and Chinese General Anxiety Disorder Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global General Anxiety Disorder Therapeutics industry with a focus on the Chinese market. The report provides key statistics on t…
- 双極性障害治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. Scope of the Report: This report studies the Bipolar Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, prod…
- 強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025 Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive dis…